Management of Transitory Loss of Consciousness and Syncopes in the Emergency Department

Sponsor
University Hospital, Clermont-Ferrand (Other)
Overall Status
Recruiting
CT.gov ID
NCT05575934
Collaborator
(none)
250
1
11.9
21

Study Details

Study Description

Brief Summary

The goal of this observational study is to examine the clinical presentations, the diagnostic tests performed and the management of patients presenting with transient loss of consciousness (TLOC)

The main questions it aims to answer are:
  • prevalence of TLOC

  • prevalence of different diagnoses leading to TLOC Demographic, clinical, paraclinical and biological data will be collected from the emergency medical file

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Patients over the age of 18 presenting to the University Hospital of Clermont-Ferrand emergency department for transient loss of consciousness of syncopal or undifferentiated origin will be include. Their non-opposition will be sought.

    Demographic, clinical, paraclinical and biological data will be collected from the emergency medical file.

    No visit is planned after the passage to the emergency room.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    250 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Management of Transitory Loss of Consciousness and Syncopes in the Emergency Department
    Actual Study Start Date :
    Oct 3, 2022
    Anticipated Primary Completion Date :
    Mar 25, 2023
    Anticipated Study Completion Date :
    Sep 30, 2023

    Outcome Measures

    Primary Outcome Measures

    1. prevalence of transient loss of consciousness in emergency department [through the study duration, an average of 6 months]

      Percentage of TLOC in emergency department

    2. prevalence of different diagnoses leading to transient loss of consciousness [through the study duration, an average of 6 months]

      Percentage of different diagnoses leading to transient loss of consciousness

    Secondary Outcome Measures

    1. prevalence of different clinical presentations of loss of consciousness [through the study duration, an average of 6 months]

      Percentage of different clinical presentations of loss of consciousness

    2. Prevalence of the various diagnostic tests carried out and the treatment of patients presenting for transient loss of consciousness [through the study duration, an average of 6 months]

      Percentage of the various diagnostic tests carried out and the treatment of patients presenting for transient loss of consciousness

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • patients over 18 presenting to the Clermont-Ferrand University Hospital emergency department for transient loss of consciousness of syncopal or undifferentiated origin
    Exclusion Criteria:
    • N/A

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 CHU Clermont-Ferrand Clermont-Ferrand France 63003

    Sponsors and Collaborators

    • University Hospital, Clermont-Ferrand

    Investigators

    • Principal Investigator: Fares Moustafa, MD, PhD, University Hospital, Clermont-Ferrand

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital, Clermont-Ferrand
    ClinicalTrials.gov Identifier:
    NCT05575934
    Other Study ID Numbers:
    • EI22MG0908
    First Posted:
    Oct 12, 2022
    Last Update Posted:
    Oct 12, 2022
    Last Verified:
    Oct 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University Hospital, Clermont-Ferrand
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 12, 2022